MHC class II antigen presentation by intestinal epithelial cells fine-tunes bacteria-reactive CD4 T cell responses
Heuberger CE. et al, (2023), Mucosal Immunology
Adipocyte autophagy limits gut inflammation by controlling oxylipin and IL‐10
Richter FC. et al, (2023), The EMBO Journal, 42
Systemic and T cell-associated responses to SARS-CoV-2 immunisation in gut inflammation (STAR SIGN study): effects of biologics on vaccination efficacy of the third dose of mRNA vaccines against SARS-CoV-2.
Woelfel S. et al, (2023), Alimentary pharmacology & therapeutics, 57, 103 - 116
Hermansky-Pudlak syndrome type 1 causes impaired anti-microbial immunity and inflammation due to dysregulated immunometabolism
Cavounidis A. et al, (2022), Mucosal Immunology, 15, 1431 - 1446
Bone Morphogenetic Protein Pathway Antagonism by Grem1 Regulates Epithelial Cell Fate in Intestinal Regeneration
Koppens MAJ. et al, (2021), Gastroenterology, 161, 239 - 254.e9
Author Correction: A dynamic CD2-rich compartment at the outer edge of the immunological synapse boosts and integrates signals
Demetriou P. et al, (2021), Nature Immunology, 22, 99 - 99
A dynamic CD2-rich compartment at the outer edge of the immunological synapse boosts and integrates signals
Demetriou P. et al, (2020), Nature Immunology, 21, 1232 - 1243
The Interleukin 22 Pathway Interacts with Mutant KRAS to Promote Poor Prognosis in Colon Cancer
McCuaig S. et al, (2020), Clinical Cancer Research, 26, 4313 - 4325
Development of a uniform, very aggressive disease phenotype in all homozygous carriers of the NOD2 mutation p.Leu1007fsX1008 with Crohn’s disease and active smoking status resulting in ileal stenosis requiring surgery
Schnitzler F. et al, (2020), PLOS ONE, 15, e0236421 - e0236421
TCR and Inflammatory Signals Tune Human MAIT Cells to Exert Specific Tissue Repair and Effector Functions
Leng T. et al, (2019), Cell Reports, 28, 3077 - 3091.e5
Cytokine Networks in the Pathophysiology of Inflammatory Bowel Disease
Friedrich M. et al, (2019), Immunity, 50, 992 - 1006
Oncostatin M drives intestinal inflammation and predicts response to tumor necrosis factor–neutralizing therapy in patients with inflammatory bowel disease
West NR. et al, (2017), Nature Medicine, 23, 579 - 589
Solid Organ Transplantation in Patients with Inflammatory Bowel Diseases (IBD): Analysis of Transplantation Outcome and IBD Activity in a Large Single Center Cohort
Schnitzler F. et al, (2015), PLOS ONE, 10, e0135807 - e0135807
Lipocalin-2 Is a Disease Activity Marker in Inflammatory Bowel Disease Regulated by IL-17A, IL-22, and TNF-α and Modulated by IL23R Genotype Status
Stallhofer J. et al, (2015), Inflammatory Bowel Diseases, 1 - 1
The NOD2 Single Nucleotide Polymorphism rs72796353 (IVS4+10 A>C) Is a Predictor for Perianal Fistulas in Patients with Crohn's Disease in the Absence of Other NOD2 Mutations
Schnitzler F. et al, (2015), PLOS ONE, 10, e0116044 - e0116044
Intestinal neuroendocrine cells and goblet cells are mediators of IL-17A-amplified epithelial IL-17C production in human inflammatory bowel disease
Friedrich M. et al, (2015), Mucosal Immunology, 8, 943 - 958
The NOD2 p.Leu1007fsX1008 Mutation (rs2066847) Is a Stronger Predictor of the Clinical Course of Crohn's Disease than the FOXO3A Intron Variant rs12212067
Schnitzler F. et al, (2014), PLoS ONE, 9, e108503 - e108503
IL-36γ Sustains a Proinflammatory Self-amplifying Loop with IL-17C in Anti-TNF–induced Psoriasiform Skin Lesions of Patients with Crohnʼs Disease
Friedrich M. et al, (2014), Inflammatory Bowel Diseases, 20, 1891 - 1901
IL-17A Alone Weakly Affects the Transcriptome of Intestinal Epithelial Cells but Strongly Modulates the TNF-α–induced Expression of Inflammatory Mediators and Inflammatory Bowel Disease Susceptibility Genes
Friedrich M. et al, (2014), Inflammatory Bowel Diseases, 20, 1502 - 1515